Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04219956
Other study ID # RC19_0023
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 3, 2020
Est. completion date November 2027

Study information

Verified date May 2023
Source Nantes University Hospital
Contact Claire Blanchard, MD-PhD
Phone +33 (0)2 40 08 30 22
Email claire.blanchard@chu-nantes.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate if a polyamine deficient diet started 7 days prior to a major abdominal surgery (eventration cure and digestive continuity) and followed 7 days post-surgery reduces the area under the curve of the numerical pain rating scale in the 72 hours post-surgery.


Description:

Morphine derivatives are known to be a major cause of postoperative ileus and also operative hyperalgesia. Operative hyperalgesia corresponds to an increase in morphine needs postoperatively which is proportional to the morphine dose necessary during the surgery. This effect is due to two mechanisms: opioids tolerance and induced hypersensitivity. N-methyl-D-aspartate receptors (R-NMDA) play a key role in this induced hypersensitivity. Polyamines, organic compounds with several amines functions, are known R-NMDA agonists. They increase the phosphorylation of the tyrosine group within the NR2B subunit responsible for the inflammatory hyperalgesia. Limiting the binding of polyamines to the R-NMDA seems an easy, safe and efficient way to limit the hypersensitivity induced post-operatively. Most of the polyamines in the human body come from food. One study listed food regarding their polyamines content and allowed to check the safety of a polyamine deficient diet. Such a well-followed diet would allow to reduce by 20 the polyamines quantity present in the body. The aim of this study is to evaluate whether a deficient polyamine diet introduced 7 days before and continued up to 7 days after an abdominal surgery requiring the use of morphine post-operatively reduces the post-operative pain, the consumption of analgesics (morphine) post-operatively and improve the recovery ability. Abdominals surgeries concerned will be the eventration cure and digestive continuity. The medico-economic impact will be observed during this study.


Recruitment information / eligibility

Status Recruiting
Enrollment 278
Est. completion date November 2027
Est. primary completion date April 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult (>18 years) - Indication for a " major " abdominal surgery as second surgical procedure : cure of eventration and restoration of digestive continuity - Intended Use of a Patient Controlled Morphine Pump (PCA) postoperatively or taking oral opioids - Possible follow-up during 7 months (post-operative consultation at 1 month and 6 months only if postoperative pain or complications) - Written informed consent form obtained from the patient - Affiliated to the social security Exclusion Criteria: - Pregnant women - Minor, adult under guardianship or benefiting from a legal protection - Oncological surgery - Surgery not painful (cholecystectomy, hernia, thyroidectomy, bariatric surgery) - Drug addicts patients, or under opiate dependency - Chronic pain patients (pain over 3 months) - Patients in nursing home or convalescence home (diet non possible in institution) - Planned hospitalisation before the intervention (during the 7 days before the surgery) - Severe undernutrition defined by the HAS criteria (weight loss > 10% in 1 month and/or > 15% in 6 months, albumin at inclusion <15g/l) - Patient refusing the possibility to change his eating habits - Oral feeding impossible preoperatively - Patient not able to express himself on their pain (silent, …) - Decompensated psychiatric pathologies (severe depression syndrome,…) - Patient unable to understand the protocol and/or to give his informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Polyamine Deficient Diet
Diet low in polyamines: the estimated calculated dose is 20 times lower that in an usual diet

Locations

Country Name City State
France CHRU Brest La Cavale Blanche Brest
France Hôpital Louis Mourier from Ap-HP Colombes
France CHD Vendée La Roche-sur-Yon
France CHU Nantes Hôtel Dieu Nantes

Sponsors (2)

Lead Sponsor Collaborator
Nantes University Hospital Centre de Recherche en Nutrition Humaine Ouest (CRNH)

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary To show a 20% decrease of the area under the curve for the numerical pain rating scale in the 72 hours post-operative in the polyamine deficient diet group To show a 20% decrease of the area under the curve for the numerical pain rating scale in the 72 hours post-operative in the polyamine deficient diet group measured every 6 hours in resting position, upon return from the operative room 72 hours post-surgery
Secondary Change in the analgesics consumption post-operatively Measure of the analgesics consumption by the nurse during hospitalisation and by the patient with the patient book up to 15 days postsurgery 15 days post-surgery
Secondary Change in the main dimension of pain Evaluation of the main dimension of pain using the Brief Pain Inventory (BPI) 6 months post-surgery
Secondary Change of the recovery time of the gas transit Evaluation of the time to recover the gas transit post-surgery (in days) 6 months post-surgery
Secondary Change of duration of urinary catheterization Recovery of spontaneous urination post-surgery (in days) 6 months post-surgery
Secondary Change in the delay before the first postoperative lift Time before walking post-surgery (in days) 6 months post-surgery
Secondary Change in length of hospitalisation stay and sick leave Hospitalisation time and sick leave (in days) 6 months post-surgery
Secondary Change in neuropathic pain: Neuropathic pain scale (DN4) Use of the Neuropathic pain scale for patients seen for their postsurgery pain or complications. The scale contains 10 questions, the range is between 0-10, 10 being the worst score. 6 months post-surgery
Secondary Change in global health status Use of autoquestionnaire EuroQol-5 Dimension (EQ-5D) to evaluate the global health status of the patients. The scale contains two parts, the first one contains 5 items to be completed by the patients with 5 levels for each item, the worst score being 55555. The second part is an analog visual scale with a range between 0-100, 0 being the worst score. 1 month before surgery, 1 month and 6 months post-surgery
Secondary Change of the recovery ability Evaluation of the recovery ability using the Quality of Recovery-15 Questionnaire (QoR-15) 1 month before surgery, 1 month and 6 months post-surgery
Secondary Change in the quality of life Assessment of the patient's quality of life by using the Short-Form Health Survey 36 questionnaire (SF-36) 1 month before surgery, 1 month and 6 months post-surgery
See also
  Status Clinical Trial Phase
Completed NCT00130715 - Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery N/A